Sadeghi Masoumeh, Khosravi-Broujeni Hossein, Salehi-Abarghouei Amin, Heidari Ramin, Masoumi Gholamreza, Roohafza Hamidreza
Professor, Cardiac Rehabilitation Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
School of Medicine AND Menzies Health Institute, Griffith University, Southport, Queensland, Australia.
ARYA Atheroscler. 2018 Mar;14(2):85-94. doi: 10.22122/arya.v14i2.1489.
This systematic review and meta-analysis aimed to assess the effect of cardiac rehabilitation (CR) on serum C-reactive protein (CRP) as an indicator of the inflammatory state and predictor of recurrent cardiovascular events.
PubMed, SCOPUS, Cochrane library, and Google Scholar databases were searched up to January 2014 for original articles which investigated the effect of CR on CRP among adult patients with previous cardiovascular events. The random effects model was used to assess the overall effect of CR on the variation in serum CRP levels.
In the present systematic review and meta-analysis, 15 studies were included. The analysis showed that CR might significantly reduce high-sensitivity CRP (hs-CRP) levels [Difference in means (DM) = -1.81 mg/l, 95% confidence interval (CI): -2.65, -0.98; P = 0.004). However, the heterogeneity between studies was significant (Cochran's Q test, P < 0.001, I-squared = 84.9%). To find the source of variation, the studies were categorized based on study design (quality) and duration. The negative effect was higher among studies which followed their participants for 3 weeks or less (DM = -2.75 mg/l, 95% CI: -3.86, -1.64; P < 0.001) compared to studies which investigated the effect of CR for 3-8 weeks (DM = -0.89 mg/l, 95% CI: -1.35, -0.44; P < 0.001) and those which lasted more than 8 weeks (DM = -1.71 mg/l, 95% CI: -2.53, -0.89; P < 0.001). There was no evidence of heterogeneity when the categorization was based on the follow-up period.
Both short- and long-term CR have resulted in improvement in serum hs-CRP levels. CR can be perceived as a beneficial tool to reduce inflammatory markers among patients with previous cardiac events.
本系统评价和荟萃分析旨在评估心脏康复(CR)对血清C反应蛋白(CRP)的影响,CRP是炎症状态的指标和心血管事件复发的预测因子。
截至2014年1月,检索了PubMed、SCOPUS、Cochrane图书馆和谷歌学术数据库,以查找研究CR对既往有心血管事件的成年患者CRP影响的原始文章。采用随机效应模型评估CR对血清CRP水平变化的总体影响。
在本系统评价和荟萃分析中,纳入了15项研究。分析表明,CR可能显著降低高敏CRP(hs-CRP)水平[均值差异(DM)=-1.81mg/l,95%置信区间(CI):-2.65,-0.98;P=0.004]。然而,研究之间的异质性显著( Cochr an检验,P<0.001,I²=84.9%)。为了找出变异来源,根据研究设计(质量)和持续时间对研究进行分类。与研究CR 3至8周(DM=-0.89mg/l,95%CI:-1.35,-0.44;P<0.001)和持续超过8周(DM=-1.71mg/l,95%CI:-2.53,-0.89;P<0.001)的研究相比,随访参与者3周或更短时间的研究中负面影响更高。当根据随访期进行分类时,没有异质性的证据。
短期和长期CR均导致血清hs-CRP水平改善。CR可被视为降低既往有心脏事件患者炎症标志物的有益工具。